Raman Singh, Juniper Biologics
Raman Singh, Juniper Biologics
19 March 2024
Why It Matters: Addressing the challenge of access to therapy for the elderly in Singapore
Singapore’s recent budget announcement has placed the ageing society in Singapore as a key priority. And this means that the entire care ecosystem in Singapore must play its part in enhancing the accessibility and affordability of treatments, to ensure the elderly and their caregivers fulfil the promises of the Budget 2024.
Raman Singh, CEO, Juniper Biologics shares how his company is looking a making quality therapy accessible to our silver generation.
Download this podcast.
Listen To His Previous Podcasts:
10 October 2022
Mind Your Business: Striking a balance between pharmaceutical innovation and accessibility to medication
The pharmaceutical industry has gone through heaps and bounds of multiple shake ups due to the Covid-19 pandemic. And as we move forward, it has become more important than ever to strike a balance between pharmaceutical innovation and accessibility to medication.Raman Singh, Chief Executive Officer, Juniper Biologics shares with us on how his company are looking ways to support Singapore’s efforts to be the next frontier in pharmaceutical services.
Download the podcast.